Protagonist Therapeutics, Inc
Total Trades
49
Buys
0
Sells
33
Largest Trade
N/A
Insiders
6
Institutional Funds
260
Inst. Value
$1M+
Activist Filings
44
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Williams Lewis T | Director | SELL | $1M+ | 18K | $82.42 | Feb 18, 2026 |
| Williams Lewis T | Director | EXERCISE | $100K–$500K | 18K | $10.84 | Feb 18, 2026 |
| Waddill William D. | Director | SELL | $1M+ | 20K | $83.68 | Feb 6, 2026 |
| Waddill William D. | Director | EXERCISE | $100K–$500K | 20K | $8.31 | Feb 6, 2026 |
| PATEL DINESH V PH D | President and CEO | EXERCISE | $500K+ | 48K | $10.79 | Jan 28, 2026 |
| PATEL DINESH V PH D | President and CEO | SELL | $1M+ | 48K | $84.18 | Jan 28, 2026 |
| Ali Asif | CFO | EXERCISE | $100K–$500K | 28K | $16.18 | Jan 28, 2026 |
| Ali Asif | CFO | SELL | $1M+ | 46K | $83.13 | Jan 28, 2026 |
| MOLINA ARTURO MD | Chief Medical Offi… | EXERCISE | $50K–$100K | 10K | $8.04 | Jan 28, 2026 |
| MOLINA ARTURO MD | Chief Medical Offi… | SELL | $1M+ | 23K | $82.30 | Jan 28, 2026 |
| MOLINA ARTURO MD | Chief Medical Offi… | SELL | $500K+ | 10K | $82.48 | Jan 21, 2026 |
| PATEL DINESH V PH D | President and CEO | SELL | $1M+ | 34K | $82.48 | Jan 21, 2026 |
| Ali Asif | CFO | SELL | $500K+ | 9K | $82.48 | Jan 21, 2026 |
| MOLINA ARTURO MD | Chief Medical Offi… | SELL | $100K–$500K | 3K | $84.77 | Nov 19, 2025 |
| Waddill William D. | Director | SELL | $100K–$500K | 4K | $64.25 | Sep 25, 2025 |
| Waddill William D. | Director | SELL | $100K–$500K | 4K | $59.25 | Aug 29, 2025 |
| PATEL DINESH V PH D | President and CEO | SELL | $500K+ | 10K | $54.78 | Jul 28, 2025 |
| PATEL DINESH V PH D | President and CEO | SELL | $1M+ | 52K | $54.92 | Jul 23, 2025 |
| PATEL DINESH V PH D | President and CEO | GRANT | N/A | 25K | — | Jul 23, 2025 |
| MOLINA ARTURO MD | Chief Medical Offi… | SELL | $1M+ | 20K | $56.27 | Jun 11, 2025 |
| MOLINA ARTURO MD | Chief Medical Offi… | EXERCISE | $100K–$500K | 20K | $8.04 | Jun 11, 2025 |
| Ali Asif | CFO | SELL | $50K–$100K | 2K | $46.00 | Apr 23, 2025 |
| Waddill William D. | Director | SELL | $100K–$500K | 4K | $54.25 | Mar 19, 2025 |
| MOLINA ARTURO MD | Chief Medical Offi… | SELL | $1M+ | 31K | $55.74 | Mar 14, 2025 |
| MOLINA ARTURO MD | Chief Medical Offi… | EXERCISE | $500K+ | 31K | $24.48 | Mar 14, 2025 |
| Ali Asif | CFO | SELL | $1M+ | 25K | $58.73 | Mar 14, 2025 |
| Ali Asif | CFO | EXERCISE | $100K–$500K | 25K | $14.90 | Mar 14, 2025 |
| PATEL DINESH V PH D | President and CEO | SELL | $100K–$500K | 5K | $38.18 | Feb 20, 2025 |
| MOLINA ARTURO MD | Chief Medical Offi… | SELL | N/A | 4K | — | Jan 17, 2025 |
| Ali Asif | CFO | SELL | N/A | 4K | — | Jan 17, 2025 |
| MOLINA ARTURO MD | Chief Medical Offi… | EXERCISE | $100K–$500K | 32K | $8.04 | Nov 28, 2024 |
| MOLINA ARTURO MD | Chief Medical Offi… | SELL | $1M+ | 32K | $44.86 | Nov 28, 2024 |
| Gupta Suneel | Chief Development … | SELL | $1M+ | 123K | $45.96 | Nov 28, 2024 |
| Gupta Suneel | Chief Development … | EXERCISE | $1M+ | 205K | $8.40 | Nov 28, 2024 |
| PATEL DINESH V PH D | President and CEO | EXERCISE | $15K–$50K | 2K | $21.58 | Nov 28, 2024 |
| PATEL DINESH V PH D | President and CEO | SELL | $1M+ | 100K | $46.81 | Nov 28, 2024 |
| MOLINA ARTURO MD | Chief Medical Offi… | SELL | $50K–$100K | 2K | $40.98 | Nov 19, 2024 |
| Waddill William D. | Director | SELL | $100K–$500K | 8K | $35.00 | Jun 11, 2024 |
| Waddill William D. | Director | EXERCISE | $100K–$500K | 8K | $12.88 | Jun 11, 2024 |
| PATEL DINESH V PH D | President and CEO | SELL | $1M+ | 35K | $35.19 | Jun 11, 2024 |
| Ali Asif | CFO | SELL | $15K–$50K | 1K | $25.11 | Apr 20, 2024 |
| PATEL DINESH V PH D | President and CEO | SELL | $500K+ | 25K | $28.31 | Apr 3, 2024 |
| PATEL DINESH V PH D | President and CEO | SELL | $500K+ | 30K | $31.62 | Mar 2, 2024 |
| Waddill William D. | Director | SELL | $100K–$500K | 13K | $31.34 | Mar 2, 2024 |
| Waddill William D. | Director | EXERCISE | $50K–$100K | 13K | $6.09 | Mar 2, 2024 |
| Ali Asif | CFO | EXERCISE | $100K–$500K | 12K | $12.17 | Mar 2, 2024 |
| Ali Asif | CFO | SELL | $500K+ | 24K | $31.60 | Mar 2, 2024 |
| MOLINA ARTURO MD | Chief Medical Offi… | GRANT | N/A | 26K | — | Jan 5, 2024 |
| MOLINA ARTURO MD | Chief Medical Offi… | SELL | $15K–$50K | 2K | $16.24 | Jan 5, 2024 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 260 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| STATE STREET CORP | 3.2M | $1M+ | SH |
| JOHNSON & JOHNSON | 2.4M | $1M+ | SH |
| PERCEPTIVE ADVISORS LLC | 1.4M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.3M | $1M+ | SH |
| ADAR1 Capital Management, LLC | 1.0M | $1M+ | SH |
| ADAR1 Capital Management, LLC | 1.0M | $1M+ | SH |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 572K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 557K | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 535K | $1M+ | SH |
| Pictet Asset Management Holding SA | 530K | $1M+ | SH |
| Clearbridge Investments, LLC | 490K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 372K | $1M+ | SH |
| PRINCIPAL FINANCIAL GROUP INC | 344K | $1M+ | SH |
| JENNISON ASSOCIATES LLC | 331K | $1M+ | SH |
| GOLDMAN SACHS GROUP INC | 306K | $1M+ | SH |
| NEXTBio Capital Management LP | 230K | $1M+ | SH |
| KENNEDY CAPITAL MANAGEMENT LLC | 221K | $1M+ | SH |
| Skandinaviska Enskilda Banken AB (publ) | 206K | $1M+ | SH |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 203K | $1M+ | SH |
| Alyeska Investment Group, L.P. | 200K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Wellington Management Group LLP
SC 13G · Feb 10, 2026
5.1%
3.2M shares
Farallon Capital Partners, L.P.
SC 13G/A · Feb 6, 2026
0.5%
283K shares
SC 13G/A · Jan 30, 2026
8.7%
5.4M shares
SC 13G/A · Nov 14, 2025
2.1%
1.3M shares
SC 13G/A · Nov 14, 2025
2.8%
1.7M shares
SC 13G/A · Oct 17, 2025
13.8%
8.6M shares
SC 13G · Aug 11, 2025
5.2%
3.2M shares
SC 13G · Jun 16, 2025
2.7%
1.7M shares
SC 13G · May 13, 2025
4.4%
2.7M shares
SC 13G/A · Apr 29, 2025
14.8%
9.1M shares
SC 13G · Apr 10, 2025
5.3%
3.3M shares
Farallon Capital Partners, L.P.
SC 13G/A · Feb 10, 2025
0.5%
298K shares
SC 13G/A · Feb 5, 2025
16.6%
9.9M shares
Biotechnology Value Fund, L.P.
SC 13G/A · Nov 14, 2024
2.6%
1.5M shares
SC 13G/A · Nov 12, 2024
7.2%
4.2M shares
SC 13G/A · Nov 4, 2024
7.2%
4.2M shares
STATE STREET CORPORATION 04-2456637
SC 13G · Oct 16, 2024
5.4%
3.2M shares
SC 13G/A · Aug 7, 2024
18.2%
10.7M shares
SC 13G/A · Feb 14, 2024
0.0%
6 shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 14, 2024
5.4%
3.1M shares
SC 13G/A · Feb 14, 2024
9.2%
5.3M shares
Point72 Asset Management, L.P.
SC 13G/A · Feb 14, 2024
4.5%
2.6M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
5.5%
3.2M shares
Farallon Capital Partners, L.P.
SC 13G/A · Feb 2, 2024
0.7%
387K shares
SC 13G/A · Jan 24, 2024
9.6%
5.5M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Jan 23, 2024
4.7%
0 shares
Point72 Asset Management, L.P.
SC 13G · Dec 18, 2023
5.5%
3.2M shares
SC 13G · Apr 13, 2023
5.4%
3.0M shares
Biotechnology Value Fund, L.P.
SC 13G · Mar 20, 2023
5.1%
2.6M shares
SC 13G/A · Feb 14, 2023
7.3%
3.6M shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 13, 2023
1.2%
578K shares
Farallon Capital Partners, L.P.
SC 13G/A · Feb 9, 2023
1.2%
601K shares
SC 13G/A · Jan 31, 2023
7.4%
3.7M shares
SC 13G/A · Jan 11, 2023
5.0%
2.4M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Jan 10, 2023
7.7%
0 shares
SC 13G · Jan 3, 2023
3.6%
6 shares
SC 13G/A · Dec 12, 2022
0.8%
386K shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Jul 11, 2022
13.9%
0 shares
SC 13G/A · Jun 10, 2022
7.3%
3.6M shares
Consonance Capital Management LP
SC 13G/A · Feb 14, 2022
0.0%
0 shares
SC 13G/A · Feb 14, 2022
5.4%
2.6M shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 12, 2022
5.5%
2.6M shares
Farallon Capital Partners, L.P.
SC 13G/A · Feb 11, 2022
0.8%
387K shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G · Feb 10, 2022
5.4%
0 shares